DK431784A - Oxopyrimidin-derivater og farmaceutiske praeparater som indeholder dem - Google Patents
Oxopyrimidin-derivater og farmaceutiske praeparater som indeholder dem Download PDFInfo
- Publication number
- DK431784A DK431784A DK431784A DK431784A DK431784A DK 431784 A DK431784 A DK 431784A DK 431784 A DK431784 A DK 431784A DK 431784 A DK431784 A DK 431784A DK 431784 A DK431784 A DK 431784A
- Authority
- DK
- Denmark
- Prior art keywords
- sub
- pharmaceutical preparations
- preparations containing
- hydrogen
- compounds
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000000049 anti-anxiety effect Effects 0.000 abstract 1
- 230000001773 anti-convulsant effect Effects 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/62—Barbituric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL6972283 | 1983-09-14 | ||
| IL69722A IL69722A (en) | 1983-09-14 | 1983-09-14 | Oxopyrimidine derivatives and pharmaceutical compositions containing them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK431784D0 DK431784D0 (da) | 1984-09-11 |
| DK431784A true DK431784A (da) | 1985-03-15 |
| DK167615B1 DK167615B1 (da) | 1993-11-29 |
Family
ID=11054532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK431784A DK167615B1 (da) | 1983-09-14 | 1984-09-11 | Barbitursyrederivater og farmaceutiske praeparater indeholdende saadanne |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4628056A (da) |
| EP (1) | EP0137343B1 (da) |
| JP (1) | JPH0730044B2 (da) |
| AT (1) | ATE70056T1 (da) |
| AU (1) | AU571265B2 (da) |
| DE (1) | DE3485318D1 (da) |
| DK (1) | DK167615B1 (da) |
| IE (1) | IE58038B1 (da) |
| IL (1) | IL69722A (da) |
| ZA (1) | ZA847274B (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0223037A1 (de) * | 1985-10-24 | 1987-05-27 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Phenylbarbitursäuren und deren Herstellung |
| US6093820A (en) * | 1997-10-02 | 2000-07-25 | Taro Pharmaceutical Industries Ltd. | Method and reagents for N-alkylating ureides |
| CA2306170A1 (en) * | 2000-04-18 | 2001-10-18 | Kenneth Curry | Novel amino, carboxy derivatives of barbituric acid |
| US7683071B2 (en) * | 2000-07-26 | 2010-03-23 | Taro Pharmaceuticals Industries Ltd. | Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid |
| US7166610B2 (en) * | 2002-12-11 | 2007-01-23 | Taro Pharmaceuticals U.S.A., Inc. | Method of treating movement disorders using barbituric acid derivatives |
| IL154060A0 (en) * | 2000-07-26 | 2003-07-31 | Taro Pharma Ind | Mon-sedating barbiturate compounds as neuroprotective agents |
| US6939873B2 (en) * | 2000-07-26 | 2005-09-06 | Taro Pharmaceuticals Industries Limited | Non-sedating barbituric acid derivatives |
| US6756379B2 (en) | 2001-07-26 | 2004-06-29 | Taro Pharmaceutical Industries Ltd. | Non-sedating barbiturate compounds as neuroprotective agents |
| AU2007200460B2 (en) * | 2000-07-26 | 2009-10-08 | Taro Pharmaceutical Industries Ltd. | Non-sedating barbiturate compounds as neuroprotective agents |
| EP1905441A3 (en) * | 2000-07-26 | 2008-04-23 | Taro Pharmaceutical Industries Limited | Non-sedating barbiturate compounds as neuroprotective agents |
| RU2196579C2 (ru) * | 2001-02-08 | 2003-01-20 | Амурская государственная медицинская академия | Способ снижения уровня тревожности у лабораторных животных в эксперименте |
| CN1291720C (zh) * | 2002-01-30 | 2006-12-27 | 塔罗制药工业有限公司 | 非镇静性巴比土酸衍生物 |
| US6810318B2 (en) * | 2002-09-13 | 2004-10-26 | General Motors Corporation | Drive torque transfer scheme |
| WO2006003651A2 (en) * | 2004-07-02 | 2006-01-12 | Taro Pharmaceutical Industries, Ltd | A process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid |
| EP1625848A1 (en) * | 2004-08-10 | 2006-02-15 | Taro Pharmaceuticals North America, Inc. | Composition and method for enhanced delivery of 5,5-diphenyl barbituric acid |
| EP2081576A4 (en) * | 2006-11-14 | 2010-06-30 | Taro Pharmaceuticals North Ame | METHOD FOR IMPROVING BIOAVAILABILITY FOR NON-EDMING BARBITURATES |
| JP6050363B2 (ja) * | 2011-09-12 | 2016-12-21 | カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ | アリール化β−ジカルボニル化合物とその製造方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1960170A (en) * | 1934-05-22 | Cc - phenylethyl - n - | ||
| US3930006A (en) * | 1963-04-30 | 1975-12-30 | Aspro Nicholas Ltd | Antiparkinsonism compositions and method |
| US4046894A (en) * | 1968-08-05 | 1977-09-06 | Bristol-Myers Company | Certain barbituric acid derivatives used as anticonvulsant agents |
| US3919427A (en) * | 1972-06-02 | 1975-11-11 | Kendall & Co | Therapeutic compositions containing 1-methyl-3-alkoxymethyl-5,5-disubstituted barbituric acid compounds |
| US3948896A (en) * | 1973-02-28 | 1976-04-06 | The Kendall Company | N-mono(alkoxymethyl) phenobarbitals, process therefor and therapeutic composition and method containing same |
-
1983
- 1983-09-14 IL IL69722A patent/IL69722A/xx not_active IP Right Cessation
-
1984
- 1984-09-05 US US06/647,680 patent/US4628056A/en not_active Expired - Lifetime
- 1984-09-10 AU AU32875/84A patent/AU571265B2/en not_active Ceased
- 1984-09-11 DK DK431784A patent/DK167615B1/da not_active IP Right Cessation
- 1984-09-13 DE DE8484110959T patent/DE3485318D1/de not_active Expired - Lifetime
- 1984-09-13 JP JP19241384A patent/JPH0730044B2/ja not_active Expired - Lifetime
- 1984-09-13 IE IE233284A patent/IE58038B1/en not_active IP Right Cessation
- 1984-09-13 EP EP84110959A patent/EP0137343B1/en not_active Expired - Lifetime
- 1984-09-13 AT AT84110959T patent/ATE70056T1/de not_active IP Right Cessation
- 1984-09-14 ZA ZA847274A patent/ZA847274B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA847274B (en) | 1986-04-30 |
| IL69722A0 (en) | 1983-12-30 |
| JPH0730044B2 (ja) | 1995-04-05 |
| US4628056A (en) | 1986-12-09 |
| EP0137343A3 (en) | 1986-06-11 |
| DK431784D0 (da) | 1984-09-11 |
| IL69722A (en) | 1986-09-30 |
| DE3485318D1 (de) | 1992-01-16 |
| ATE70056T1 (de) | 1991-12-15 |
| DK167615B1 (da) | 1993-11-29 |
| IE58038B1 (en) | 1993-06-16 |
| IE842332L (en) | 1985-03-14 |
| EP0137343B1 (en) | 1991-12-04 |
| JPS6084272A (ja) | 1985-05-13 |
| AU3287584A (en) | 1985-03-21 |
| AU571265B2 (en) | 1988-04-14 |
| EP0137343A2 (en) | 1985-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK431784D0 (da) | Oxopyrimidin-derivater og farmaceutiske praeparater som indeholder dem | |
| NL1002835A1 (nl) | Synergistisch stabilisatormengsel. | |
| DK0530087T3 (da) | Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| NO180538C (no) | N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene | |
| ID27124A (id) | Penghambat kinase bisiklik | |
| MX9700557A (es) | Dihidrobenzofuranos. | |
| NZ240282A (en) | Phenyl pyrazole derivatives; herbicidal compositions and use, and preparatory processes | |
| NO904595L (no) | Fremgangsmaate for potensiering av den analgetiske effekt av curcuminoider. | |
| ATE231839T1 (de) | Polyaromatische antivirale zusammensetzungen | |
| ES2001106A6 (es) | Procedimiento para la obtencion de 1-aril-pirazoles | |
| ES8505927A1 (es) | Procedimiento para la preparacion de derivados de 1-(fenil)-1-hidroxi-2-amino-3-fluoro-propano | |
| IS4367A (is) | CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín | |
| DK1056771T3 (da) | Streptograminderivater, deres fremstilling og præparater, der indeholder dem | |
| DK0490816T3 (da) | Fluorforbindelser som aromatase-inhibitorer. | |
| MX9702203A (es) | Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida. | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| SE8302751L (sv) | 2(1h)-pyridinonderivat, deras framstellning och farmaceutiska beredningar som innehaller dem | |
| DK259589D0 (da) | Joderede, ikke-ioniske trijodbenzenforbindelser og kontrastmiddel indeholdende dem | |
| ATE141248T1 (de) | Neue bis-phenyl-hexene | |
| ATE204847T1 (de) | Tetracyclische aromatische retinoide verbindungen,ihre herstellung und verwendung | |
| AU590200B2 (en) | Aroyl substituted dihydro-1,4-thiazines | |
| DK151082A (da) | Fungicidt middel indeholdende triazolylderivater | |
| IT8421331A0 (it) | Composizioni e procedimento per la stabilizzazione di antralina. | |
| DK316188A (da) | Sulfolipopolysaccharider som stimolatorer for den ikke specifikke forsvarsmekanisme | |
| ES474052A1 (es) | Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PUP | Patent expired |